Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 270 No 7238 p291-295
1 March 2003


News summary

Branch meetings   Future Events   Conferences 

291 DoH issues guide to implementation of supplementary prescribing online The Department of Health has issued a guide for implementation of supplementary prescribing in England. The guide, which applies to pharmacists and nurses, explains how such prescribing will work and who can undertake it and covers legal, training and evaluation issues...[more]

291 NICE says "no" to amantadine for influenza treatment The National Institute for Clinical Excellence has recommended that amantadine (Lysovir) should not be used for the treatment of influenza...[more]

292 Promising result for low-dose warfarin A study of low-dose warfarin treatment has been stopped early because of promising results in patients with recurrent venous thromboembolism...[more]

292 Fear of vascular disease should not stop HIV therapy Concerns about possible cardiovascular complications of antiretroviral therapy should not prevent its use, say researchers...[more]

292 New eczema cream works well in young infants Pimecrolimus (Elidel) cream is an effective treatment for atopic dermatitis in infants as young as three months, according to the authors of a new study...[more]

293 Politicians are petitioned Petitions signed by pharmacy customers opposing the deregulation of pharmacy contracts have been presented to politicians in Scotland and England...[more]

293 Not too late to lobby MPs, says NPA V-C Pharmacists should continue lobbying Members of Parliament until the April closure date for consultations on the Office of Fair Trading report, National Pharmaceutical Association vice-chairman Hemant Patel is urging...[more]

293 Generic manufacturer opposes changes to child-resistant packs Packaging aspirin, paracetamol and iron preparations in blister packs that meet a new child-resistance standard will not improve patient safety, the United Kingdom's largest generics manufacturer claims...[more]

293 UK medicines sales up in 2002 Sales of medicines in the United Kingdom grew by 10 per cent to $10.8bn (£6.9bn) in the year to December 2002 — the biggest growth in Europe — according to figures from IMS Health...[more]

294 Tell quitters of increase in colds and mouth ulcers Smokers trying to stop should be informed that they have an increased chance of developing mouth ulcers or cold symptoms, authors of a new study say...[more]

294 Call to revive palliative care group Pharmacists from four hospitals in the United Kingdom are hoping to revive a palliative care interest group and are calling on other pharmacists to register their interest...[more]

294 More people quit smoking Almost 55,000 smokers gave up smoking last year with help from National Health Service smoking cessation services...[more]

294 Improvement in 'flu vaccine uptake An extra 350,000 elderly people were immunised against influenza this winter compared with last winter with over 5.5 million people aged 65 years and over being vaccinated, according to the Department of Health...[more]

294 Pregnant women should limit tuna Pregnant and breast feeding women, and women who intend to become pregnant, should limit their intake of tuna to no more than two medium-sized cans or one fresh tuna steak per week, says the Food Standards Agency...[more]

294 Erectile dysfunction on the up Recorded diagnoses of erectile dysfunction have more than doubled since the launch of sildenafil (Viagra) in the United Kingdom, researchers report...[more]

295 Pharmacists must help to manage the use of amiodarone in primary care Community pharmacists must be alert to the possible unwanted effects of amiodarone, according to a consultant cardiothoracic pharmacist...[more]

295 DTB calls for more research on tiotropium in COPD The Drug & Therapeutics Bulletin has called for more research on tiotropium (Spiriva) to assess its place next to cheaper and older antimuscarinic agents in chronic obstructive pulmonary disease (COPD)...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal